Brainsway Ltd (BWAY) is a Healthcare · Medical Devices company listed on NASDAQ. Price $13.63 (+0.74%), Market cap $0.61B, P/E ratio 69.45, 52-week low–high $10.19 ~ $26.04.
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Financial statements, price targets, institutional (13F) holdings and related news for Brainsway Ltd are updated in real time on BlackAll Trade.
Brainsway Ltd trades at $13.63 (+0.74%). Real-time quotes and charts are available on BlackAll Trade.
Brainsway Ltd has a market cap of about $0.61B. Its P/E ratio is 69.45.
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platfor